Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01019369 · ClinicalTrials.gov registry record · NA

Study of Self or Clinic Administration of DepoProvera

A NA study of Contraception, sponsored by Carolyn L. Westhoff.

Completed
Registry status
NA
Development phase
132
Enrollment target
1
Study location

NCT01019369: Completed NA study of Contraception, sponsored by Carolyn L. Westhoff.

NCT01019369 is a NA study of Contraception that has completed, run by Carolyn L. Westhoff. The registered enrollment target is 132 participants, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01019369, a NA study of Contraception, has completed, sponsored by Carolyn L. Westhoff.

COMPLETED
Registry status
NA
Development phase
132 participants
Enrollment target
1
Study location

Study Summary

Depot medroxyprogesterone acetate (DepoProvera) is an acceptable form of contraception for many women. However, difficulty in access may cause many women to discontinue use, often without the use of another effective method of contraception, thereby leaving them vulnerable to unintended pregnancy. This study will randomly assign women who present for contraceptive services to two groups: self or clinic administered SC DMPA. The participants will be followed for one year to compare continuation rates, acceptability, cost effectiveness, evidence of skin changes, and need for continued support between the two groups.

Primary Outcome

The study was designed to examine if increasing accessibility to DMPA by decreasing the need for multiple clinic visits will increase participant continuation of DMPA

Conditions Studied

Interventions

  • DRUG Medroxyprogesterone 17-Acetate

Study Locations (1)

New York

  • Columbia University/New York Presbyterian Hospital - New York

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2010-03
Est. Completion 2012-11
Phase NA
Carolyn L. Westhoff

1 total trials

What the finished NCT01019369 record still lists

NCT01019369 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (71% lower).

The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Medroxyprogesterone 17-Acetate is the first listed.

NCT01019369 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01019369 about?

NCT01019369 is a clinical study titled "Study of Self or Clinic Administration of DepoProvera". Depot medroxyprogesterone acetate (DepoProvera) is an acceptable form of contraception for many women. However, difficulty in access may cause many women to discontinue use, often without the use of another effective method of contraception, thereby leaving them vulnerable to unintended pregnancy. T...

What is the current status of trial NCT01019369?

This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2010-03. Estimated completion is 2012-11.

What conditions does trial NCT01019369 study?

This clinical trial studies the following conditions: Contraception.

What interventions are being tested in trial NCT01019369?

The interventions under investigation include: Medroxyprogesterone 17-Acetate (DRUG).

Who is sponsoring clinical trial NCT01019369?

This trial is sponsored by Carolyn L. Westhoff, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01019369 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01019369's enrollment target sits among peer trials

132 39th of 72 higher than 34 of 72 other Contraception trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01766297 · 132 participants · Phase 2

    Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

  • NCT04002947 · 132 participants · Phase 2

    Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

  • NCT04128189 · 132 participants · Phase 3

    Shingrix in Renal Transplant Recipients

  • NCT04199780 · 132 participants · NA

    Effects of tDCS Combined With CBI on Postsurgical Pain

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01019369, the US trial registry maintained by the National Library of Medicine. NCT01019369 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.